Publications by authors named "Su-Qing Feng"

Article Synopsis
  • The study aimed to investigate how triple antiplatelet therapy affects platelet aggregation and activation in patients who had coronary stenting, comparing it with dual antiplatelet therapy.
  • It involved 120 patients who were divided into two groups, with one group receiving aspirin and clopidogrel plus cilostazol while the other received only aspirin and clopidogrel.
  • Results indicated that while some measures of platelet activation (such as CD62p and PAC-1) were significantly higher in the triple therapy group, the differences in platelet aggregation rates were not statistically significant between the two groups.
View Article and Find Full Text PDF

Objective: To evaluate short-term efficacy and safety of triple antiplatelet regimen (cilostazol combined with clopidogrel and aspirin) in patients who underwent percutaneous coronary intervention (PCI).

Methods: From October 2001 to April 2005, a total of 3135 patients underwent PCI in the General Hospital of Shenyang Command, People's Liberation Army, of which 1103 were treated with cilostazol 100 mg twice a day for 6 months in addition to aspirin and clopidogrel for 3 - 12 months as triple antiplatelet therapy regimen (triple group) after PCI, and 2032 of which received aspirin and clopidogrel for 3 - 12 months as dual antiplatelet therapy regimen after PCI (control group). The data of the incidence rates of major adverse cardiac events (MACE), subacute in-stent thrombosis (SAT), and hemorrhage events within 30 days after PCI of the two groups were retrospectively analyzed.

View Article and Find Full Text PDF